Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TreatAIN: Cidofovir vs Sinecatechins vs Electrocoagulation for HGAIN
NCT04055142Phase 3Completed
- Sponsor
- Vall d'Hebron Research Institute
- Start
- Sep 2020
- Primary completion
- Jan 2024
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cidofovir, sinecatechins in anal intraepithelial neoplasia (AIN), sponsored by Vall d'Hebron Research Institute. Started Sep 2020; status: completed.
02
Drugs
cidofovirsinecatechins
03
Conditions
anal intraepithelial neoplasia (AIN)
Beyond the preview
Go deeper on NCT04055142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04055142.